Beyond the IFN-&ggr; horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis

Latent infection with Mycobacterium tuberculosis (LTBI) is defined by the presence of M. tuberculosis-specific immunity in the absence of active tuberculosis. LTBI is detected using interferon-&ggr; release assays (IGRAs) or the tuberculin-skin-test (TST). In clinical practice, IGRAs and the TSTs have failed to distinguish between active tuberculosis and LTBI and their predictive value to identify individuals at risk for the future development of tuberculosis is limited. There is an urgent need to identify biomarkers that improve the clinical performance of current immunodiagnostic methods for tuberculosis prevention, diagnosis and treatment monitoring. Here, we review the landscape of potential alternative biomarkers useful for detection of infection with M. tuberculosis. We describe what individual markers add in terms of specificity for active/latent infection, prediction of progression to active tuberculosis and immunodiagnostic potential in high-risk groups' such as HIV-infected individuals and children. The field of biomarkers for the guidance of clinical management of patients with tuberculosis is rapidly evolving http://ow.ly/r2Ep2

[1]  Mingli Liu,et al.  The emerging role of CXCL10 in cancer (Review). , 2011, Oncology letters.

[2]  Juan Ma,et al.  Costimulatory molecule expression on human uveal melanoma cells: functional analysis of CD40 and B7-H1. , 2012, Experimental eye research.

[3]  L. Cuevas,et al.  Use of tuberculin skin test, IFN-&ggr; release assays and IFN-&ggr;-induced protein-10 to identify children with TB infection , 2012, European Respiratory Journal.

[4]  J. Van Damme,et al.  Macrophage inflammatory protein-1. , 2002, Cytokine & growth factor reviews.

[5]  R. Renneberg,et al.  Biosensing for the 21st Century , 2008 .

[6]  J Coste,et al.  Reliability of Tuberculin Skin Test Measurement , 1997, Annals of Internal Medicine.

[7]  Delia Goletti,et al.  Is IP-10 an Accurate Marker for Detecting M. tuberculosis-Specific Response in HIV-Infected Persons? , 2010, PloS one.

[8]  S. Hoffman,et al.  Expression of the chemokine MIG is a sensitive and predictive marker for antigen-specific, genetically restricted IFN-γ production and IFN-γ-secreting cells , 2001 .

[9]  B. Walker,et al.  A Molecular Assay for Sensitive Detection of Pathogen-Specific T-Cells , 2011, PloS one.

[10]  K Dheda,et al.  Interferon-&ggr; release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis , 2010, European Respiratory Journal.

[11]  Alimuddin Zumla,et al.  Immunological biomarkers of tuberculosis , 2011, Nature Reviews Immunology.

[12]  D. Goletti,et al.  Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  T. McDade,et al.  A highly sensitive immunoassay for interleukin‐6 in dried blood spots , 2012, American journal of human biology : the official journal of the Human Biology Council.

[14]  Xue-guang Zhang,et al.  Distinct Effect of CD40 and TNF-Signaling on the Chemokine/Chemokine Receptor Expression and Function of the Human Monocyte-Derived Dendritic Cells , 2008, Cellular and Molecular Immunology.

[15]  A. Raja,et al.  Interferon gamma and interferon gamma inducible protein-10 in detecting tuberculosis infection. , 2012, The Journal of infection.

[16]  William C. Whitworth,et al.  Multiple Cytokines Are Released When Blood from Patients with Tuberculosis Is Stimulated with Mycobacterium tuberculosis Antigens , 2011, PloS one.

[17]  C. Locht,et al.  Heparin-Binding-Hemagglutinin-Induced IFN-γ Release as a Diagnostic Tool for Latent Tuberculosis , 2007, PloS one.

[18]  D. Goletti,et al.  IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis. , 2013, The Journal of infection.

[19]  C. Crescioli,et al.  CXCL10: a candidate biomarker in transplantation. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[20]  Wenhong Zhang,et al.  Evaluation of the Diagnostic Potential of IP-10 and IL-2 as Biomarkers for the Diagnosis of Active and Latent Tuberculosis in a BCG-Vaccinated Population , 2012, PloS one.

[21]  J. Bennedsen,et al.  Proteins released from Mycobacterium tuberculosis during growth , 1991, Infection and immunity.

[22]  H. Tanke,et al.  Lateral flow assay for simultaneous detection of cellular- and humoral immune responses. , 2011, Clinical biochemistry.

[23]  Wenhong Zhang,et al.  Novel Biomarkers Distinguishing Active Tuberculosis from Latent Infection Identified by Gene Expression Profile of Peripheral Blood Mononuclear Cells , 2011, PloS one.

[24]  J. Hibbert,et al.  CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications , 2011, Cytokine & growth factor reviews.

[25]  Y. Sasaki,et al.  Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. , 2004, American journal of respiratory and critical care medicine.

[26]  P. Proost,et al.  Human monocyte chemotactic proteins‐2 and ‐3: structural and functional comparison with MCP‐1 , 1996, Journal of leukocyte biology.

[27]  A. Luster,et al.  CXCR3 ligands: redundant, collaborative and antagonistic functions , 2011, Immunology and cell biology.

[28]  C. Hsieh,et al.  Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[29]  M. Gagliardi,et al.  Cytometric detection of antigen-specific IFN-γ/IL-2 secreting cells in the diagnosis of tuberculosis , 2009, BMC infectious diseases.

[30]  C. Gioia,et al.  IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. , 2012, The Journal of infection.

[31]  P. Ravn,et al.  Biomarkers of latent TB infection , 2009, Expert review of respiratory medicine.

[32]  P. Van de Perre,et al.  Multicytokine Detection Improves Latent Tuberculosis Diagnosis in Health Care Workers , 2012, Journal of Clinical Microbiology.

[33]  A. Benedetti,et al.  Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[34]  B. Kampmann,et al.  Is IP-10 a Better Biomarker for Active and Latent Tuberculosis in Children than IFNγ? , 2008, PloS one.

[35]  G. Schoolnik,et al.  Comparative genomics of BCG vaccines by whole-genome DNA microarray. , 1999, Science.

[36]  R. Cornall,et al.  A whole blood monokine-based reporter assay provides a sensitive and robust measurement of the antigen-specific T cell response , 2011, Journal of Translational Medicine.

[37]  R. Basu Roy,et al.  Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study. , 2012, American journal of respiratory and critical care medicine.

[38]  Gerhard Walzl,et al.  Detection and treatment of subclinical tuberculosis. , 2012, Tuberculosis.

[39]  F. Cobelens,et al.  Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts , 2009, European Respiratory Journal.

[40]  P. Andersen,et al.  Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infection. , 2011, Journal of immunological methods.

[41]  John Chan,et al.  What's good for the host is good for the bug. , 2005, Trends in microbiology.

[42]  Q. Hamid,et al.  The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. , 1999, Journal of immunology.

[43]  A. Lalvani,et al.  A 100 year update on diagnosis of tuberculosis infection. , 2010, British medical bulletin.

[44]  P. Andersen,et al.  Immune Responses to ESAT-6 and CFP-10 by FASCIA and Multiplex Technology for Diagnosis of M. tuberculosis Infection; IP-10 Is a Promising Marker , 2012, PloS one.

[45]  G. Bai,et al.  Deciphering the proteome of the in vivo diagnostic reagent “purified protein derivative” from Mycobacterium tuberculosis , 2012, Proteomics.

[46]  M. Ernst,et al.  Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection , 2009, European Respiratory Journal.

[47]  H. Mollenkopf,et al.  Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors , 1998, European journal of immunology.

[48]  M. Pai.  Spectrum of latent tuberculosis — existing tests cannot resolve the underlying phenotypes , 2010, Nature Reviews Microbiology.

[49]  M. Ernst,et al.  Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot , 2008, European Respiratory Journal.

[50]  H. Gaines,et al.  Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. , 2006, Cytokine.

[51]  A. Luster,et al.  CXCR3 in T cell function. , 2011, Experimental cell research.

[52]  T. Whittall,et al.  Innate Immunity and HIV-1 Infection , 2011, Advances in dental research.

[53]  F. Cobelens,et al.  LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement , 2009, European Respiratory Journal.

[54]  D. Hougaard,et al.  Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. , 2005, Clinical chemistry.

[55]  S. Rowland-Jones,et al.  Polyfunctional CD4+ and CD8+ T Cell Responses to Tuberculosis Antigens in HIV-1–Infected Patients before and after Anti-Retroviral Treatment , 2010, The Journal of Immunology.

[56]  P. Ravn,et al.  Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper , 2013, European Respiratory Journal.

[57]  S. Kaufmann,et al.  Mycobacterium tuberculosis: success through dormancy. , 2012, FEMS microbiology reviews.

[58]  Kristian Kofoed,et al.  CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. , 2007, Microbes and infection.

[59]  L. Richeldi,et al.  A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. , 2011, Tuberculosis.

[60]  K. Laserson,et al.  Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee. , 2012, American journal of respiratory and critical care medicine.

[61]  J. Panee.  Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes. , 2012, Cytokine.

[62]  Shabir Madhi,et al.  Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. , 2012, The Journal of infectious diseases.

[63]  M. Lipman,et al.  Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. , 2007, American journal of respiratory and critical care medicine.

[64]  T. van der Poll,et al.  Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis. , 1998, American journal of respiratory and critical care medicine.

[65]  H. Kirchner,et al.  A whole-blood technique for testing production of human interferon by leukocytes. , 1982, Journal of immunological methods.

[66]  H. Pollack,et al.  Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[67]  L. Cuevas,et al.  Can Interferon-Gamma or Interferon-Gamma-Induced-Protein-10 Differentiate Tuberculosis Infection and Disease in Children of High Endemic Areas? , 2011, PloS one.

[68]  F. Chang,et al.  Identification of Cytokines in Whole Blood for Differential Diagnosis of Tuberculosis versus Pneumonia , 2010, Clinical and Vaccine Immunology.

[69]  M. Amicosante,et al.  Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[70]  T. Ottenhoff,et al.  Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection. , 2011, Vaccine.

[71]  G. Schoolnik,et al.  Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. , 2006, Microbes and infection.

[72]  R. Al-Attiyah,et al.  Characterization of Human Cellular Immune Responses to Novel Mycobacterium tuberculosis Antigens Encoded by Genomic Regions Absent in Mycobacterium bovis BCG , 2008, Infection and Immunity.

[73]  É. Hajduch,et al.  IL‐1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde? , 2006, FEBS letters.

[74]  J. Deeks,et al.  Novel M tuberculosis Antigen-Specific T-Cells Are Early Markers of Infection and Disease Progression , 2011, PloS one.

[75]  Ralph Andre,et al.  Quantitative polymerase chain reaction. , 2014, British journal of hospital medicine.

[76]  P. Andersen,et al.  Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis , 1995, Infection and immunity.

[77]  M. Pai,et al.  Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[78]  Xinjing Wang,et al.  Diagnostic performance of multiplex cytokine and chemokine assay for tuberculosis. , 2012, Tuberculosis.

[79]  M. Brennan,et al.  Tuberculosis vaccines: a strategic blueprint for the next decade. , 2012, Tuberculosis.

[80]  E. W. Hoskyns,et al.  Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk , 2012, Thorax.

[81]  N. Range,et al.  The Impact of HIV Infection and CD4 Cell Count on the Performance of an Interferon Gamma Release Assay in Patients with Pulmonary Tuberculosis , 2009, PloS one.

[82]  J. Flynn,et al.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies , 2009, Nature Reviews Microbiology.

[83]  P. Ravn,et al.  A Simple Method to Quantitate IP-10 in Dried Blood and Plasma Spots , 2012, PloS one.

[84]  B. Marston,et al.  Interferon-Gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in HIV-Infected Individuals: A Systematic Review and Meta-Analysis , 2011, Journal of acquired immune deficiency syndromes.

[85]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[86]  Kouros Owzar,et al.  Discriminating between latent and active tuberculosis with multiple biomarker responses. , 2011, Tuberculosis.

[87]  K. Dobos,et al.  Purified protein derivatives of tuberculin--past, present, and future. , 2012, FEMS immunology and medical microbiology.

[88]  Xinchun Chen,et al.  Different Patterns of Cytokines and Chemokines Combined with IFN-γ Production Reflect Mycobacterium tuberculosis Infection and Disease , 2012, PloS one.

[89]  P. Hopewell,et al.  Messenger RNA Expression of IL-8, FOXP3, and IL-12β Differentiates Latent Tuberculosis Infection from Disease1 , 2007, The Journal of Immunology.

[90]  R. Diel,et al.  Interferon-&ggr; release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis , 2010, European Respiratory Journal.

[91]  S. Cooperband,et al.  Immune Specific Induction of Interferon Production in Cultures of Human Blood Lymphocytes , 1969, Science.

[92]  R. Casetti,et al.  Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)‐infected individuals enrolled with suspected active tuberculosis: a pilot study , 2007, Clinical and experimental immunology.

[93]  Venkatesan Perumal,et al.  Role of QuantiFERON-TB Gold, Interferon Gamma Inducible Protein-10 and Tuberculin Skin Test in Active Tuberculosis Diagnosis , 2010, PloS one.

[94]  G. Schoolnik,et al.  A multistage tuberculosis vaccine that confers efficient protection before and after exposure , 2011, Nature Medicine.

[95]  Kristian Kofoed,et al.  Improving T-Cell Assays for the Diagnosis of Latent TB Infection: Potential of a Diagnostic Test Based on IP-10 , 2008, PloS one.

[96]  J V Mei,et al.  Use of filter paper for the collection and analysis of human whole blood specimens. , 2001, The Journal of nutrition.

[97]  J. Flynn,et al.  Macrophages and control of granulomatous inflammation in tuberculosis , 2011, Mucosal Immunology.

[98]  H. Dockrell,et al.  CCL2 Responses to Mycobacterium tuberculosis Are Associated with Disease Severity in Tuberculosis , 2009, PloS one.

[99]  T. Bodmer,et al.  Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis , 2008, European Respiratory Journal.

[100]  Kendall A. Smith,et al.  Interleukin-2: inception, impact, and implications. , 1988, Science.

[101]  A. Lalvani,et al.  IGRAs--the gateway to T cell based TB diagnosis. , 2013, Methods.

[102]  Mahavir Singh,et al.  Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis , 2012, PloS one.

[103]  G. Opdenakker,et al.  Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. , 1994, Journal of immunology.

[104]  B. Walker,et al.  Prospective Monitoring Reveals Dynamic Levels of T Cell Immunity to Mycobacterium Tuberculosis in HIV Infected Individuals , 2012, PloS one.

[105]  S. Kaufmann,et al.  Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting , 2012, BMC Infectious Diseases.

[106]  T. Ottenhoff,et al.  Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection , 2009, European Respiratory Journal.

[107]  Ajit Lalvani,et al.  Enumeration of Functional T-Cell Subsets by Fluorescence-Immunospot Defines Signatures of Pathogen Burden in Tuberculosis , 2010, PloS one.

[108]  A. Cerami,et al.  Induction of the Chemokine β Peptides, MIP-1α and MIP-1β, by Lipopolysaccharide Is Differentially Regulated by Immunomodulatory Cytokines γ-IFN, IL-10, IL-4, and TGF-β , 1998 .

[109]  A. Raja,et al.  Multiplex analysis of cytokines/chemokines as biomarkers that differentiate healthy contacts from tuberculosis patients in high endemic settings. , 2013, Cytokine.

[110]  S. Kaufmann,et al.  Potential of Host Markers Produced by Infection Phase-Dependent Antigen-Stimulated Cells for the Diagnosis of Tuberculosis in a Highly Endemic Area , 2012, PloS one.

[111]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[112]  Y. Sasaki,et al.  Specific Detection of Tuberculosis Infection: An Interferon-γ–based Assay Using New Antigens , 2004 .

[113]  P. Andersen,et al.  Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG , 1996, Infection and immunity.

[114]  G. Ippolito,et al.  IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. , 2010, The Journal of infection.

[115]  T. Malek,et al.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity. , 2010, Immunity.

[116]  U. Wahn,et al.  Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: A case–control study , 2012, Scandinavian journal of infectious diseases.

[117]  Sang-Nae Cho,et al.  Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[118]  P. Sass.  Tuberculosis infection and disease in children. , 1996, American Family Physician.

[119]  A. Mandalakas,et al.  Utility of Host Markers Detected in Quantiferon Supernatants for the Diagnosis of Tuberculosis in Children in a High-Burden Setting , 2013, PloS one.

[120]  A. Raja,et al.  Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects. , 2011, Diagnostic microbiology and infectious disease.

[121]  R. Küffner,et al.  Microfluidic high-throughput RT-qPCR measurements of the immune response of primary bovine mammary epithelial cells cultured from milk to mastitis pathogens. , 2013, Animal : an international journal of animal bioscience.

[122]  S. Sridhar,et al.  Redefining latent tuberculosis. , 2011, Future microbiology.

[123]  R. Diel,et al.  Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. , 2012, Chest.

[124]  Tom H. M. Ottenhoff,et al.  Enhancing Sensitivity of Detection of Immune Responses to Mycobacterium leprae Peptides in Whole-Blood Assays , 2010, Clinical and Vaccine Immunology.

[125]  Young Keun Kim,et al.  Interferon gamma mRNA quantitative real-time polymerase chain reaction for the diagnosis of latent tuberculosis: a novel interferon gamma release assay. , 2013, Diagnostic microbiology and infectious disease.

[126]  R. Eberhardt,et al.  Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study. , 2009, American journal of respiratory and critical care medicine.

[127]  A. Rieger,et al.  Reversion and conversion of interferon-γ release assay results in HIV-1-infected individuals. , 2014, The Journal of infectious diseases.

[128]  N. Range,et al.  Potential of interferon-&ggr;-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients , 2010, European Respiratory Journal.

[129]  C. Wiysonge,et al.  The Utility of an Interferon Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection and Disease in Children: A Systematic Review and Meta-analysis , 2011, The Pediatric infectious disease journal.

[130]  G. Cooke,et al.  T-Cell Immunophenotyping Distinguishes Active From Latent Tuberculosis , 2013, The Journal of infectious diseases.

[131]  D. T. Carr.  The tuberculin skin test. , 1972, The American review of respiratory disease.

[132]  T. Ottenhoff,et al.  Monokine induced by interferon gamma and IFN-gamma response to a fusion protein of Mycobacterium tuberculosis ESAT-6 and CFP-10 in Brazilian tuberculosis patients. , 2006, Microbes and infection.

[133]  H. Kotilainen,et al.  Evaluation of the filter paper IP-10 tests in school children after exposure to tuberculosis: a prospective cohort study with a 4-year follow-up , 2012, BMJ Open.

[134]  P. Escalante.  Tuberculosis , 1904, Annals of Internal Medicine.

[135]  D. Tse,et al.  Cytokine responses to QuantiFERON® peptides, purified protein derivative and recombinant ESAT-6 in children with tuberculosis. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[136]  P. Fink,et al.  Immune Vulnerability of Infants to Tuberculosis , 2013, Clinical & developmental immunology.

[137]  D. Sherman,et al.  Bioinformatic and Empirical Analysis of Novel Hypoxia-Inducible Targets of the Human Antituberculosis T Cell Response , 2012, The Journal of Immunology.

[138]  Joon Chang,et al.  The Responses of Multiple Cytokines Following Incubation of Whole Blood from TB Patients, Latently Infected Individuals and Controls with the TB Antigens ESAT‐6, CFP‐10 and TB7.7 , 2012, Scandinavian journal of immunology.

[139]  Gerhard Walzl,et al.  Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report , 2009, BMC pulmonary medicine.

[140]  Bjoern Peters,et al.  Memory T Cells in Latent Mycobacterium tuberculosis Infection Are Directed against Three Antigenic Islands and Largely Contained in a CXCR3+CCR6+ Th1 Subset , 2013, PLoS pathogens.

[141]  S. Kaufmann,et al.  For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection , 2011, Immunological reviews.

[142]  S. Fortune,et al.  Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection , 2011, Proceedings of the National Academy of Sciences.

[143]  D. Hougaard,et al.  Antigen-induced cytokine and chemokine release test for tuberculosis infection using adsorption of stimulated whole blood on filter paper and multiplex analysis , 2012, Scandinavian journal of clinical and laboratory investigation.

[144]  M. Kubista,et al.  Detection of immune cell response to M. tuberculosis-specific antigens by quantitative polymerase chain reaction. , 2012, Diagnostic microbiology and infectious disease.

[145]  E. Curis,et al.  TNF-α/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study , 2012, Pediatric Research.

[146]  Jan Dirks,et al.  Whole-Blood Flow-Cytometric Analysis of Antigen-Specific CD4 T-Cell Cytokine Profiles Distinguishes Active Tuberculosis from Non-Active States , 2011, PloS one.

[147]  P. Klenerman,et al.  MIGRAs: are they the new IGRAs? Development of monokine-amplified IFN-γ release assays. , 2012, Biomarkers in medicine.

[148]  G. Pantaleo,et al.  Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease , 2011, Nature Medicine.

[149]  P. Ravn,et al.  IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay , 2009, BMC Research Notes.

[150]  Dirk Repsilber,et al.  Novel strategies to identify biomarkers in tuberculosis , 2008, Biological chemistry.

[151]  D. Goletti,et al.  Screening for latent infection with Mycobacterium tuberculosis: a plea for targeted testing in low endemic regions , 2012, Expert review of molecular diagnostics.

[152]  Z. Hasan,et al.  Differential Live Mycobacterium tuberculosis-, M. bovis BCG-, Recombinant ESAT6-, and Culture Filtrate Protein 10-Induced Immunity in Tuberculosis , 2009, Clinical and Vaccine Immunology.

[153]  P. Ravn,et al.  IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions , 2012, Expert review of molecular diagnostics.

[154]  Z. Hasan,et al.  ESAT6-Induced IFNγ and CXCL9 Can Differentiate Severity of Tuberculosis , 2009, PloS one.

[155]  Reinhard Renneberg,et al.  New trends in immunoassays. , 2008, Advances in biochemical engineering/biotechnology.

[156]  T. Cohen,et al.  Controversies and unresolved issues in tuberculosis prevention and control: a low-burden-country perspective. , 2012, The Journal of infectious diseases.

[157]  M. Rottenberg,et al.  Mycobacterium tuberculosis Sonicate–Induced IFNγ, CXCL10 and IL10 can Differentiate Severity in Tuberculosis , 2012, Scandinavian journal of immunology.

[158]  G. Ippolito,et al.  IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy , 2011, BMC infectious diseases.

[159]  B. D. de Jong,et al.  Production of TNF-α, IL-12(p40) and IL-17 Can Discriminate between Active TB Disease and Latent Infection in a West African Cohort , 2010, PloS one.

[160]  L. Li,et al.  ESAT‐6‐ and CFP‐10‐Specific Th1, Th22 and Th17 Cells in Tuberculous Pleurisy May Contribute to the Local Immune Response Against Mycobacterium Tuberculosis Infection , 2011, Scandinavian journal of immunology.

[161]  Y. Ohmori,et al.  Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. , 1993, The American journal of pathology.

[162]  R. Adegbola,et al.  Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease , 2009, European journal of immunology.

[163]  P. Andersen,et al.  Specific immune-based diagnosis of tuberculosis , 2000, The Lancet.

[164]  Virginia Pascual,et al.  An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.

[165]  W. Arend.  The balance between IL-1 and IL-1Ra in disease. , 2002, Cytokine & growth factor reviews.

[166]  S. Pestka,et al.  The interferon gamma (IFN-γ) receptor: a paradigm for the multichain cytokine receptor , 1997 .

[167]  G. Kaplan,et al.  Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial Load , 2011, The Journal of Immunology.

[168]  L. Cuevas,et al.  Interferon Gamma–induced Protein-10 Concentrations in Children With Previous Tuberculosis Infections and Disease , 2012, The Pediatric infectious disease journal.

[169]  G. Stark,et al.  Roles of IKK-beta, IRF1, and p65 in the activation of chemokine genes by interferon-gamma. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[170]  P. Klenerman,et al.  Dynamic Relationship between IFN-γ and IL-2 Profile of Mycobacterium tuberculosis-Specific T Cells and Antigen Load1 , 2007, The Journal of Immunology.

[171]  A. Whelan,et al.  DIVA reagents for bovine tuberculosis vaccines in cattle , 2011, Expert review of vaccines.

[172]  D. de Groote,et al.  Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. , 1992, Cytokine.

[173]  J. Finke,et al.  Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. , 1990, The Journal of biological chemistry.

[174]  C. Chee,et al.  Diagnosis and treatment of latent infection with Mycobacterium tuberculosis , 2013, Respirology.